A recent study shows evidence that infant formulas fortified with docosahexaenoic acid (DHA) and arachidonic acid (ARA) – two long chain polyunsaturated fatty acids – are good for developing infant brains and hearts.
The study, the “DHA Intake and Measurement of Neural Development” (DIAMOND) trial is published in the October 2011 issue of Pediatric Research. It is the first double-blind, randomized, controlled, prospective trial to study the cognitive effects of a wide range of DHA concentrations provided in infant formulas. The study was conducted by researchers at the University of Kansas and the University of Kansas Medical Center.
Mead Johnson was proud to provide the formulas for this study as part of our ongoing commitment to advancing scientific knowledge in pediatric nutrition. We have issued a statement with more details on the study in our News section.